Monday, January 11, 201612:00– 1:30 pm, in 489 Minor Hall

Cell Therapy for Glaucoma

presented by

Jeffrey Goldberg, MD, PhD
Dept of Ophthalmology, Stanford University School of Medicine

Irreversible vision loss in glaucoma and other optic neuropathies is due in part to the loss of retinal ganglion cells and their axon connections through the optic nerve to the brain. Cl therapies designed to replace retinal ganglion cells will depend on stem or progenitor cell differentiation and integration into the visual system after transplant. Here we will discuss recent progress in our understanding of the molecular and cellular regulators of these processes.

Host: John Flanagan

← Back to Oxyopia Archive